About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Ph II Early BC Pre-Surgical Biologic Study

NCT00637026·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

With

Cancer International Research Group (CIRG)

Age

18–any

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Invasive breast cancer, Aged 18 years or older, Not more than 28 days from initial diagnosis

You may not be if

Pregnant or lactating patients, Prior or current radiotherapy for breast cancer, Known allergy reaction to Iressa

The record

StatusCompleted

PhasePhase 2

Taking part65

StartedJul 2003

UpdatedApr 23, 2009

Conditions

Clareo Health | Ph II Early BC Pre-Surgical Biologic Study